On Wednesday, Cheetah Mobile Inc (ADR) (NYSE:CMCM)’s shares declined -0.15% to $33.03.
Cheetah Mobile Inc (ADR) (CMCM) the world’s leading developer of mission-critical mobile utility applications, launched the Cheetah Ad Platform, a mobile advertising technology platform that works with the world’s leading brand advertisers, publishers and developers to reach and engage with global consumer audiences at scale.
Cheetah Mobile’s owned and operated mobile applications (Cheetah Apps) and media ad network (Cheetah MediaLink) are united to provide brands with the unique opportunity to reach the right audience, at the right time, in the right format to attract users throughout the purchase cycle. These key pillars of the Cheetah Ad Platform provide massive global reach, while ensuring deep engagement and performance through its innovative ad formats, audience targeting technology and conversion optimization solutions.
As a leading mobile app developer, providing consumers with a speedier, simpler and safer mobile experience, Cheetah Mobile has developed a large, global user base comprised of loyal and engaged consumers. In the first quarter of 2015, its total global mobile installations reached 1.34 billion users and its mobile monthly active users reached over 440 million. In addition, Cheetah Mobile has expanded its media reach through key acquisitions of Zoom Interactive and MobPartner to complement and diversify its mobile network.
Cheetah Mobile Inc. operates a platform that offer mobile and PC applications for users and global content distribution channels for business partners in China. The company’s suite of applications optimizes mobile and PC Internet system performance and provides real time protection against known and unknown security threats. Its mobile and PC applications for users comprise Clean Master, a junk file cleaning, memory boosting, and privacy protection tool for mobile devices; CM Security, an anti-virus and security application for mobile devices; Battery Doctor, a power optimization tool for mobile devices; Cheetah Browser, a safe Web browser for PCs and mobile devices; and CM Launcher, which is a secure launcher that offers acceleration, secure protection, and stylish wallpapers, in addition to automatically organizes mobile phones based on personal behavior; Photo Grid, a photo collage application that allows users to create professional looking collages of photos through an intuitive interface for mobile devices; and Duba Anti-virus, an Internet security application for PC and mobile devices.
DS Healthcare Group Inc (NASDAQ:DSKX)’s shares dropped 17.74% to $3.71.
DS Healthcare Group Inc (DSKX) DS Healthcare Group is searching for a Chief Marketing Officer, to bolster sales of its consumer products business.
The company has not had any marketing activities to date and its entire revenue stream comes from organic sales through its distribution network. Focusing on its core competencies of developing personal care products and new drug therapies in previous times, the company will now support its retail distribution with a robust marketing plan.
The ideal candidate is an practiced executive who can link company efforts and use of resources to specific growth and performance objectives. The Chief Marketing Officer must execute marketing strategies that are central to DS Healthcare’s corporate DNA of disruptive product innovation and act as the voice of customers internally.
DS Healthcare Group, Inc., doing business as DS Laboratories, develops and markets hair care, skin care, and personal care products in North America and internationally. Its hair care products comprise Revita and Revita LT shampoos, and Revita.Cor conditioner for hair growth stimulation; Dandrene, an antifungal shampoo to treat itchy scalp and dandruff; and Spectral line of products comprising Spectral.DNC spray formula, Spectral.DNC-L lotion, and Spectral DNC-N to re-grow hair through various pathways, in addition to Spectral.RS, a topical treatment for men and women with advanced androgenic alopecia.
At the end of Wednesday’s trade, InterCloud Systems Inc (NASDAQ:ICLD)‘s shares surged 1.71% to $2.97.
InterCloud Systems, Inc. (ICLD) a leading provider of cloud networking orchestration and automation solutions and services, declared recently that the December 2013 $11.6 Million Debenture has been paid in full and has been completely eliminated from the Company’s balance sheet.
Mark Munro, CEO of InterCloud stated: “The elimination of this debenture is very important as it lowers InterCloud’s monthly principal and interest payments by over $400,000. This is an important milestone as this will provide InterCloud with additional working capital with which to grow the business as we move forward.
InterCloud Systems, Inc. provides end-to-end IT and network solutions to the telecommunications service provider and corporate enterprise markets through cloud platforms and professional services in the United States and internationally. It operates through three segments: Applications and Infrastructure, Professional Services, and Cloud and Managed Services.
Illumina, Inc. (NASDAQ:ILMN), ended its Wednesday’s trading session with -0.26% loss, and closed at $220.17.
Illumina, Inc. (ILMN) declared they have reached a contract to jointly develop advanced clinical applications for reproductive health based on next-generation sequencing (NGS) technology. The partnership signals the increasing importance of genomic applications to improve healthcare in China.
In recent years, NGS technology has evolved rapidly and is regarded as an essential factor for enabling precision medicine. The partnership between Annoroad and Illumina will focus on providing the most advanced and integrated sequencing solutions to the clinical market. In particular, the two companies will work together to develop a user-friendly, prenatal DNA diagnostic system for the Chinese market.
The partnership will bring together technology from Illumina sequencers with Annoroad’s advanced clinical application development capabilities. As part of the agreement, Annoroad will provide its nucleic acid extraction, library preparation, and data analysis software, while Illumina will provide NGS instrument components and related reagents.
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The companys products comprise sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms comprise of HiScan and iScan systems, in addition to NextSeq 550 system that are array scanners for DNA and RNA analysis applications, counting single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
